The use of medical marijuana in cancer care presents a dilemma for both patients and physicians. The scientific evidence is evolving, yet much of the known information is still insufficient to adequately inform patients as to risks and benefits. In addition, evidence-based dosing and administration information on medical marijuana is lacking.
Cannabis researchers in Canada say the plant-based drug may provide resistance to SARS-CoV-2. Their preliminary findings are part of broader research into the use of medicinal cannabis in treating cancer.